New peer-reviewed, scientific study shows Vyleesi enhances sexual brain processing in premenopausal women with HSDD. Click here to learn more ›

May 2014

New Survey Reveals That Low Sexual Desire Disrupts Relationships

RED BANK, N.J., May 20, 2014 /PRNewswire/ — Nearly one in two non-menopausal women ages 30 to 50 say they have experienced low sexual desire at some point in their lives, and many of these women (61%) felt distressed by it, according to a new national survey. Low sexual desire that is accompanied by distress …

New Survey Reveals That Low Sexual Desire Disrupts Relationships Read More »

Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on May 13, 2014

CRANBURY, N.J., May 13, 2014 /PRNewswire/ — Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, today announced results for its third quarter ended March 31, 2014.  Recent Highlights Pivotal Phase 3 clinical trials of bremelanotide for Female …

Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on May 13, 2014 Read More »

Palatin Technologies, Inc. To Report Third Quarter Fiscal Year 2014 Results

CRANBURY, N.J., May 9, 2014 /PRNewswire/ — Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its third quarter, fiscal year 2014 operating results on Tuesday, May 13, 2014 before the open of the U.S. financial markets. Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on May 13, …

Palatin Technologies, Inc. To Report Third Quarter Fiscal Year 2014 Results Read More »

Scroll to Top